Publication | Open Access
Long‐term tolerability, immunogenicity and efficacy of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in children with severe haemophilia A
14
Citations
25
References
2018
Year
Long-term treatment with Nuwiq<sup>®</sup> for the prevention of bleeds in children with severe haemophilia A was well tolerated, effective and reduced spontaneous bleeding by up to 70% compared with GENA-03.
| Year | Citations | |
|---|---|---|
Page 1
Page 1